相关实验视频

Updated: Sep 15, 2025

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

来自Rhododendron anthopogonoides的五种新的美洛特,以及它们的抗炎活性

Mengtian Li¹, Norbu Kelsang², Yongqin Zhao¹

¹State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Bioactive Natural Product Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

Chinese journal of natural medicines

|July 13, 2025

概括

来自Rhododendron anthopogonoides的新型美类药物显示出抗炎作用的潜力. 化合物1和3在细胞模型中有效降低了炎症标志物,这表明了治疗应用.

科学领域:

自然产品化学化学
药理学药理学是指药理学的学科.
药用化学医学化学

背景情况:

Rhododendron物种是生物活性天然产品的丰富来源.
梅罗特类是具有多种生物活动的复杂化合物.
炎症在各种疾病中起着关键作用.

研究的目的:

从Rhododendron anthopogonoides中分离和描述新型的美类植物.
为了评估隔离化合物的抗炎作用.
为了阐明抗炎活性的作用机制.

主要方法:

使用色谱技术分离和净化化合物.
通过HR-ESI-MS,UV,IR和NMR光谱学来阐明结构.
使用电子圆二元论 (ECD) 确定绝对配置.
在体外抗炎试验中,使用RAW264.7用脂多糖 (LPS) 刺激的细胞进行了抗炎试验.

主要成果:

鉴定出了五种新的美洛特类 (rhodonoids K-M,daurichromene E,grifolins A-B) 化合物.
化合物1和3显著抑制了LPS诱导的炎症.
观察到抑制了促炎性细胞因子mRNA (IL-1β,IL-6,TNF-α) 和蛋白质 (iNOS,COX-2) 的表达.

结论:

罗多龙 (Rhododendron anthopogonoides) 是一种具有抗炎性质的新型甲类植物的来源.
化合物1和3代表潜在的炎症条件的治疗线索.
对详细的机制和体内疗效的进一步研究是有必要的.

关键词:

抗炎药物抗炎药物抗炎药物隔离和识别方式自然产品是天然产品.Rhododendron的athopogonosides 马克西姆的时间西藏医学是西藏医学.

更多相关视频

Author Spotlight: Developing Identification Methods for Rhodiola crenulata and Investigating Its Resource Distribution and Pharmacological Effects

Author Spotlight: Developing Identification Methods for Rhodiola crenulata and Investigating Its Resource Distribution and Pharmacological Effects

Published on: October 27, 2023

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

相关概念视频

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Antiasthma Drugs: Muscarinic Receptor Antagonists

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...